Crispr Therapeutics Stock Forecast - 8 Period Moving Average
| CRSP Stock | USD 55.65 0.76 1.35% |
The 8 Period Moving Average forecasted value of Crispr Therapeutics AG on the next trading day is expected to be 56.01 with a mean absolute deviation of 4.27 and the sum of the absolute errors of 230.72. Crispr Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Crispr Therapeutics stock prices and determine the direction of Crispr Therapeutics AG's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Crispr Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Crispr Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Crispr Therapeutics' systematic risk associated with finding meaningful patterns of Crispr Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Crispr Therapeutics to cross-verify your projections. Crispr |
Open Interest Against 2024-04-26 Crispr Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Crispr Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Crispr Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Crispr Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Crispr Therapeutics' open interest, investors have to compare it to Crispr Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Crispr Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Crispr. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Crispr Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Crispr Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Crispr Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
An 8-period moving average forecast model for Crispr Therapeutics is based on an artificially constructed time series of Crispr Therapeutics daily prices in which the value for a trading day is replaced by the mean of that value and the values for 8 of preceding and succeeding time periods. This model is best suited for price series data that changes over time. Crispr Therapeutics 8 Period Moving Average Price Forecast For the 26th of April
Given 90 days horizon, the 8 Period Moving Average forecasted value of Crispr Therapeutics AG on the next trading day is expected to be 56.01 with a mean absolute deviation of 4.27, mean absolute percentage error of 24.94, and the sum of the absolute errors of 230.72.Please note that although there have been many attempts to predict Crispr Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Crispr Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Crispr Therapeutics Stock Forecast Pattern
| Backtest Crispr Therapeutics | Crispr Therapeutics Price Prediction | Buy or Sell Advice |
Crispr Therapeutics Forecasted Value
In the context of forecasting Crispr Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Crispr Therapeutics' downside and upside margins for the forecasting period are 52.73 and 59.29, respectively. We have considered Crispr Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Crispr Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Crispr Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 108.462 |
| Bias | Arithmetic mean of the errors | 0.7818 |
| MAD | Mean absolute deviation | 4.2727 |
| MAPE | Mean absolute percentage error | 0.0594 |
| SAE | Sum of the absolute errors | 230.7238 |
Predictive Modules for Crispr Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Crispr Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Crispr Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Crispr Therapeutics
For every potential investor in Crispr, whether a beginner or expert, Crispr Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Crispr Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Crispr. Basic forecasting techniques help filter out the noise by identifying Crispr Therapeutics' price trends.Crispr Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Crispr Therapeutics stock to make a market-neutral strategy. Peer analysis of Crispr Therapeutics could also be used in its relative valuation, which is a method of valuing Crispr Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Crispr Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Crispr Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Crispr Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Crispr Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Crispr Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Crispr Therapeutics shares will generate the highest return on investment. By undertsting and applying Crispr Therapeutics stock market strength indicators, traders can identify Crispr Therapeutics AG entry and exit signals to maximize returns.
| Accumulation Distribution | 36244.5 | |||
| Daily Balance Of Power | (0.33) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 56.64 | |||
| Day Typical Price | 56.31 | |||
| Price Action Indicator | (1.37) | |||
| Period Momentum Indicator | (0.76) | |||
| Relative Strength Index | 25.27 |
Crispr Therapeutics Risk Indicators
The analysis of Crispr Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Crispr Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting crispr stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.58 | |||
| Standard Deviation | 3.32 | |||
| Variance | 11.02 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Crispr Therapeutics Investors Sentiment
The influence of Crispr Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Crispr. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Crispr Therapeutics' public news can be used to forecast risks associated with an investment in Crispr. The trend in average sentiment can be used to explain how an investor holding Crispr can time the market purely based on public headlines and social activities around Crispr Therapeutics AG. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Crispr Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Crispr Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Crispr Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Crispr Therapeutics.
Crispr Therapeutics Implied Volatility | 86.17 |
Crispr Therapeutics' implied volatility exposes the market's sentiment of Crispr Therapeutics AG stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Crispr Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Crispr Therapeutics stock will not fluctuate a lot when Crispr Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Crispr Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Crispr Therapeutics' short interest history, or implied volatility extrapolated from Crispr Therapeutics options trading.
Pair Trading with Crispr Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crispr Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Crispr Stock
| 0.74 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.64 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.55 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to Crispr Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Crispr Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Crispr Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Crispr Therapeutics AG to buy it.
The correlation of Crispr Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Crispr Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Crispr Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Crispr Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Crispr Therapeutics to cross-verify your projections. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Crispr Stock analysis
When running Crispr Therapeutics' price analysis, check to measure Crispr Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crispr Therapeutics is operating at the current time. Most of Crispr Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crispr Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crispr Therapeutics' price. Additionally, you may evaluate how the addition of Crispr Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Crispr Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Crispr Therapeutics. If investors know Crispr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Crispr Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.94) | Revenue Per Share 4.686 | Quarterly Revenue Growth 33.5 K | Return On Assets (0.06) | Return On Equity (0.08) |
The market value of Crispr Therapeutics is measured differently than its book value, which is the value of Crispr that is recorded on the company's balance sheet. Investors also form their own opinion of Crispr Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Crispr Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Crispr Therapeutics' market value can be influenced by many factors that don't directly affect Crispr Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Crispr Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Crispr Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Crispr Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.